U.S. markets closed

Trucept, Inc. (TREP)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0720+0.0097 (+15.57%)
At close: 3:34PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
Previous Close0.0623
Open0.0725
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0667 - 0.0725
52 Week Range0.0255 - 0.1399
Volume20,400
Avg. Volume62,590
Market Cap3.619M
Beta (5Y Monthly)-12.37
PE Ratio (TTM)N/A
EPS (TTM)-0.1600
Earnings DateMay 21, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Trucept Inc. Announces First Quarter 2021 Results
    Business Wire

    Trucept Inc. Announces First Quarter 2021 Results

    Trucept Inc. (OTC Pink: TREP) has released its updated financials for Q1 2021. The company has experienced another consecutive quarter of profitability, as Trucept reported revenues of $3.8 million for the period (an increase from 48.76 percent over the previous year).

  • Trucept Inc. Publishes Year-End Report for 2020
    Business Wire

    Trucept Inc. Publishes Year-End Report for 2020

    Trucept Inc. (OTC Pink: TREP) recently published its year-end report for 2020 on March 31. The report shows $12.3 million in revenues versus $9.4 million in 2019. The increase is largely from great success in management fees that the company specializes in, CEO Norman Tipton said.

  • Trucept Adds Robbe to Board of Directors
    PR Newswire

    Trucept Adds Robbe to Board of Directors

    Trucept Inc. (OTC Pink: TREP) furthered its board compliance strategy by adding independent attorney and businessman, Fletcher Robbe, to its Board of Directors.